Proud to see that our effort is acknowledged in the very interesting upcoming book: OBO Semantic Engineer Training. The contribution was exemplified as best practice in the “How to be an Open Science Engineer – maximising impact for a better world” chapter. The work was made under the auspice of CIAO project and was part … Read More
News
Navigating the biological unknown
Biovista combines augmented and artificial intelligence to drive new possibilities for safer, more-precise medicines. See here for more…
Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum™ Next-Generation Protein Sequence Platform Output
Partnership Joins Protein Sequencing Technology With AI Visualization to Further Unlock the Human Proteome for Novel Drug Discovery Key Takeaways January 09, 2023 08:00 AM Eastern Standard Time GUILFORD, Conn.–(BUSINESS WIRE)–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership and license agreement with … Read More
Biovista Presentation in NIH’s Predictive Toxicology Branch DNTP
Eftychia Lekka, Ph.D. and Vassilis Virvilis, Ph.D Biovista Efforts to standardize important concepts and relationships using established Terminologies in the AOP Knowledge Base at NIH’s Predictive Toxicology Branch DNTP Seminar on Friday June 24 2022. The presentation will summarize a systematic approach on reviewing and categorizing user-entered data issues in the Adverse Outcome Pathway (AOP) … Read More
Biovista Personalized Medicine and Diginova to deliver next generation AI-driven doctor/patient support in a deal that can generate over $5 Billion.
CHARLOTTESVILLE, Va. and DUBAI, UAE, Sept. 15, 2021 /PRNewswire/ — Biovista Personalized Medicine and Diginova Health Solutions today announced their deal to deliver augmented intelligence (AI)-driven personalized medicine analytics to over a quarter of a billion patients in Asia, starting in the MENA region. Diginova will offer Biovista Personalized Medicine’s market-leading AI Health ShieldTM analytics direct-to-consumer, … Read More